Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autolog... von Zweegman, Sonja, Stege, Claudia A M, Haukas, Einar, Schjesvold, Fredrik H, Levin, Mark-David, Waage, Anders, Leys, Rineke B L, Klein, Saskia K, Szatkowski, Damian, Axelsson, Per, Hieu Do, Trung, Knut-Bojanowska, Dorota, van der Spek, Ellen, Svirskaite, Asta, Klostergaard, Anja, Salomo, Morten, Blimark, Celine, Ypma, Paula F, Mellqvist, Ulf-Henrik, Poddighe, Pino J, Stevens-Kroef, Marian, van de Donk, Niels W C J, Sonneveld, Pieter, Hansson, Markus, van der Holt, Bronno, Abildgaard, Niels

Volltext

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial von Gay, Francesca, Weisel, Katja Christina, Goldschmidt, Hartmut, Maisnar, Vladimir, Moreau, Philippe, Pluta, Agnieszka, Chng, Wee-Joo, Kaiser, Martin, Zweegman, Sonja, Spencer, Andrew, Skacel, Tomas, Palumbo, Antonio, Labotka, Richard, Fantl, Dorotea, Horvath, Neomi, Lee, Cindy, Taylor, Kerry, Spencer, Andrew, Agis, Hermine, Zojer, Niklas, Offner, Fritz, Wu, Ka Lung, Zanella, Karla, Capra, Marcelo, Araújo, Sérgio, Gregora, Evzen, Hajek, Roman, Maisnar, Vladimir, Scudla, Vlastimil, Spicka, Ivan, Abildgaard, Niels, Andersen, Niels, Jensen, Bo Amdi, Plesner, Torben, Salomo, Morten, Svirskaite, Asta, Moreau, Philippe, Goldschmidt, Hartmut, Schieferdecker, Aneta, Zeis, Matthias, Klein, Stefan, Reimer, Peter, Hoffmann, Martin, Kyrtsonis, Mary-Christine, Anagnostopoulos, Achilleas, Illés, Árpád, Borbényi, Zita, Mikala, Gabor, Dally, Najib, Horowitz, Netanel, Gutwein, Odit, Nemets, Anatoly, Vaxman, Iuliana, Trestman, Svetlana, Preis, Meir, Rossi, Giuseppe, Liberati, Anna Marina, Bosi, Alberto, Nakaseko, Chiaki, Matsumoto, Morio, Nagai, Hirokazu, Sunami, Kazutaka, Chou, Takaaki, Akashi, Koichi, Eom, Hyeon Seok, Min, Chang Ki, Yoon, Sung Soo, Kim, Kihyun, Vellenga, Edo, Grosicki, Sebastian, Pluta, Andrzej, Robak, Tadeusz, Bergantim, Rui, Goh, Yeow Tee, McDonald, Andrew, Rapoport, Bernado, Álvarez Rivas, Miguel Angel, De Arriba de La Fuente, Felipe, Mateos, Maria Victoria, Oriol Rocafiguera, Albert, San Miguel, Jesús, Alegre-Amor, Adrian, Axelsson, Per, Carlson, Kristina, Stromberg, Olga, Hansson, Markus, Liu, Ta-Chih, Huang, Shang-Yi, Unal, Ali, Goker, Hakan, Sonmez, Mehmet, Korenkova, Sybiryna, Oakervee, Heather, Sati, Hamdi, Benjamin, Reuben, Garg, Mamta, Cook, Gordon, Jenner, Matthew, Berryman, Robert, Janakiram, Murali

Volltext

Relationship between reasons for intermittent missing patient-reported outcomes data and missing data mechanisms von Nielsen, Lene Kongsgaard, Mercieca-Bebber, Rebecca, Möller, Sören, Redder, Louise, Jarden, Mary, Andersen, Christen Lykkegaard, Frederiksen, Henrik, Svirskaite, Asta, Silkjær, Trine, Steffensen, Morten Saaby, Pedersen, Per Trøllund, Hinge, Maja, Frederiksen, Mikael, Jensen, Bo Amdi, Helleberg, Carsten, Mylin, Anne Kærsgaard, Abildgaard, Niels, King, Madeleine T.

Volltext

Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autolog... von Zweegman, Sonja, Stege, Claudia A M, Haukas, Einar, Schjesvold, Fredrik H, Levin, Mark-David, Waage, Anders, Leys, Rineke B L, Klein, Saskia K, Szatkowski, Damian, Axelsson, Per, Hieu Do, Trung, Knut-Bojanowska, Dorota, van der Spek, Ellen, Svirskaite, Asta, Klostergaard, Anja, Salomo, Morten, Blimark, Celine, Ypma, Paula F, Mellqvist, Ulf-Henrik, Poddighe, Pino J, Stevens-Kroef, Marian, van de Donk, Niels W C J, Sonneveld, Pieter, Hansson, Markus, van der Holt, Bronno, Abildgaard, Niels

Volltext

Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for A... von Zweegman, Sonja, van der Holt, Bronno, Schjesvold, Fredrik H., Levin, Mark-David, Stege, Claudia A.M., Waage, Anders, Leijs, Maria Berhardina, Klein, Saskia, Szatkowski, Damian L., Broyl, A, Axelsson, Per, Hieu Do, Trung, Knut-Bojanovska, Dorota, van der Spek, Ellen, Svirskaite, Asta, Cunha, Sonia, Hansson, Markus, Sonneveld, Pieter, Haukaas, Einar, Abildgaard, Niels

Volltext

Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for A... von Zweegman, Sonja, Schjesvold, Fredrik H., van der Holt, Bronno, Levin, Mark-David, Stege, Claudia A.M., Waage, Anders, Leijs, Maria B.L., Klein, Saskia K., Szatkowski, Damian L., Axelsson, Per, Hieu Do, Trung, Knut-Bojanovska, Dorota, van der Spek, Ellen, Svirskaite, Asta, Poddighe, Pino, Stevens-Kroef, Marian, Hansson, Markus, van de Donk, Niels WCJ, Haukas, Einar, Sonneveld, Pieter, Abildgaard, Niels

Volltext

Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple... von Thidemann Andersen, Kristian, Klausen, Tobias, Abildgaard, Niels, Klarskov Andersen, Mette, Frost Andersen, Niels, Christian Frølund, Ulf, Helleberg, Carsten, Kjeldsen, Eigil, Pedersen, Per, Helm-Petersen, Sissel, Svirskaite, Asta, Preiss, Birgitte, Gimsing, Peter, Juul Vangsted, Annette

Volltext

Ixazomib‐Thalidomide‐Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long‐term Results of H... von Groen, Kazimierz, Schjesvold, Fredrik H., Holt, Bronno, Levin, Mark‐David, Seefat, Maarten R., Hansson, Markus, Leys, Maria B.L., Regelink, Josien C., Waage, Anders, Szatkowski, Damian, Axelsson, Per, Hieu Do, Trung, Svirskaite, Asta, Spek, Ellen, Haukas, Einar, Knut‐Bojanowska, Dorota, Ypma, Paula F., Blimark, Cecilie H., Mellqvist, Ulf‐Henrik, Donk, Niels W.C.J., Sonneveld, Pieter, Klostergaard, Anja, Vangsted, Annette J., Abildgaard, Niels, Zweegman, Sonja

Volltext

Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autolog... von Sonja Zweegman, Zweegman, Claudia A M Stege, A, Haukås, Einar, Schjesvold, Fredrik H, Mark-David Levin, Levin, Waage, Anders, Rineke B L Leys, B, Saskia K Klein, K, Szatkowski, Damian Lukasz, Per Axelsson, Axelsson, Trung Hieu Do, Hieu, Dorota Knut-Bojanowska, Knut-Bojanowska, Ellen van der Spek, van, Asta Svirskaite, Svirskaite, Anja Klostergaard, Klostergaard, Morten Salomo, Salomo, Celine Blimark, Blimark, Paula F Ypma, F, Ulf-Henrik Mellqvist, Mellqvist, Pino J Poddighe, J, Marian Stevens-Kroef, Stevens-Kroef, Niels W C J van de Donk, W, Pieter Sonneveld, Sonneveld, Markus Hansson, Hansson, Bronno van der Holt, van, Niels Abildgaard, Abildgaard

Volltext